ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2013
Immunization with a HSP65-HER2 fusion peptide selectively eliminates HER2(+) B16 melanoma cells in a xenograft tumor mouse model.
Junying Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.